NIH-funded research R01 grant

Exploring new ways to use glucocorticoids to treat heart issues in diabetes

Official title: Harnessing novel glucocorticoid biology to treat diabetic cardiomyopathy

Funded at Cincinnati Childrens Hosp Med Ctr · NIH-10894063 · Data updated 2026-11-12

This study is looking at how a type of steroid hormone called glucocorticoids can help improve heart function for people with diabetic cardiomyopathy, a heart issue that can happen with type-2 diabetes, by figuring out the best times to give this treatment.

More Cardiomyopathy research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr
NIH-funded
Lab location1 site (Cincinnati, United States)
Project startAugust 1, 2023
Project endJune 30, 2027
Funding year2024
Award (this year)$401,250
NIH project number5R01HL166356-02
Project IDNIH-10894063 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with type-2 diabetes who are experiencing heart-related complications.

Less likely to help

Patients without diabetes or those who do not have heart complications related to diabetes may not benefit from this research.

What this research studies

This research investigates how glucocorticoids, a type of steroid hormone, can be used to improve heart function in patients with diabetic cardiomyopathy, a common complication of type-2 diabetes. The study focuses on understanding the role of glucocorticoid receptors in heart cells and how their activity is influenced by the body's circadian rhythms. By examining the timing and frequency of glucocorticoid administration, the researchers aim to identify optimal treatment strategies that could enhance heart metabolism and function. The approach includes both laboratory studies and preliminary clinical trials to assess safety and effectiveness in humans.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for heart problems associated with diabetes, potentially enhancing patients' quality of life.

How similar studies have gone: Previous research has shown promising results with similar approaches, particularly in the context of circadian timing and glucocorticoid administration.

Where this research is happening

  • Cincinnati Childrens Hosp Med Ctr
    Cincinnati, United States
    Active

Researchers

  • Principal investigator: Quattrocelli, Mattia — Cincinnati Childrens Hosp Med Ctr
  • Study coordinator: Quattrocelli, Mattia

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.